Transforming activity of purinergic receptor P2Y, G-protein coupled, 2 revealed by retroviral expression screening

Biochem Biophys Res Commun. 2007 May 11;356(3):723-6. doi: 10.1016/j.bbrc.2007.03.048. Epub 2007 Mar 19.

Abstract

Colorectal cancer (CRC) is one of the leading causes of cancer death in humans. In order to identify novel cancer-promoting genes in CRC, we here constructed a retroviral cDNA expression library from a CRC cell line RKO, and used it for a focus formation assay with mouse 3T3 fibroblasts, leading to the identification of 42 independent cDNAs. One of such cDNAs turned out to encode purinergic receptor P2Y, G-protein coupled, 2 (P2RY2). The oncogenic potential of P2RY2 was confirmed in vitro with the focus formation assay as well as soft agar-growth assay, and also in vivo with a tumorigenicity assay in nude mice. While our P2RY2 cDNA encodes a protein with two amino-acid substitutions compared to the reported one, we have confirmed that the wild-type P2RY2 has a strong transforming potential as well. These results indicate an unexpected role of P2RY2 in the carcinogenesis of human cancers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Transformation, Viral
  • Colonic Neoplasms
  • Humans
  • Mice
  • NIH 3T3 Cells
  • Receptors, Purinergic P2 / genetics
  • Receptors, Purinergic P2 / physiology*
  • Receptors, Purinergic P2Y2

Substances

  • P2RY2 protein, human
  • P2ry2 protein, mouse
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y2